IODIM
DeviceEye drops containing polyvinylpyrrolidone-Iodine (PVP-Iodine), hyaluronic acid and triglycerides
NCT Number: NCT03958292
The purpose of the present study is to elucidate the qualitative and quantitative variation of ocular flora after treatment with eyedrops containing 0.6% povidone-iodine in the eye of patients undergoing routine cataract surgery.
Looking for future studies?
Notify Me40 year–80 year
All sexes
Interventional
Not applicable
Oftalmologia Universitaria Ospedale Policlinico di Bari, Bari, BA, Italy
Two conjunctival swabs will be executed at 3 days before and at the day of routine cataract surgery in each eye of patients undergoing routine cataract surgery. After the collection of the first conjunctival swab a three-days treatment with eyedrops containing 0.6% povidone-iodine in the eye undergoing routine cataract surgery will be performed. Bacterial isolates will be identified by using standard microbiological protocols and total bacterial load will be determined at the two different time points. In vitro susceptibility testing to determine methicillin resistance in isolated Staphylococcus species will be performed. Controlateral eye of each patient will be used as control. Descriptive statistics will be calculated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Eye drops containing polyvinylpyrrolidone-Iodine (PVP-Iodine), hyaluronic acid and triglycerides
Time frame: Three days of treatment
Variation/Eradication of bacterial load in participants with positive culture at the screening visit. This variation/Eradication will be recorded at pre-surgical visit by means of a second collection of a conjunctival swab and culture analysis. This outcome will be assessed by comparing the number of participants undergoing eradication of their initial bacterial load or decrease of bacterial load after treatment.
Ospedale Sacra Famiglia - Fatebenefratelli Erba
Other
Evaluation of Conjunctival Flora Alteration in Patients Undergoing Cataract Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06990607
Endophthalmitis Following Cataract Surgery
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT04568213
Cataract, Endophthalmitis
Loma Linda, California, United States
View Trial DetailsNCT03363295
Cataract, Endophthalmitis
Campinas, São Paulo, Brazil
View Trial DetailsNCT05249413
Cataract, Endophthalmitis
Banhā, Egypt
View Trial Details